ACANTHE DEVELOPPEMENT SA (ACAN.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ACAN • FR0000064602

0.245 EUR
+0.01 (+2.94%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

2

Overall ACAN gets a fundamental rating of 2 out of 10. We evaluated ACAN against 42 industry peers in the Diversified REITs industry. While ACAN seems to be doing ok healthwise, there are quite some concerns on its profitability. ACAN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ACAN has reported negative net income.
  • ACAN had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ACAN reported negative net income in multiple years.
  • ACAN had a positive operating cash flow in 4 of the past 5 years.
ACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

  • ACAN has a worse Return On Assets (-1.57%) than 78.57% of its industry peers.
  • ACAN has a Return On Equity of -1.87%. This is in the lower half of the industry: ACAN underperforms 76.19% of its industry peers.
  • ACAN has a Return On Invested Capital of 0.35%. This is amonst the worse of the industry: ACAN underperforms 88.10% of its industry peers.
Industry RankSector Rank
ROA -1.57%
ROE -1.87%
ROIC 0.35%
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ACAN.PA Yearly ROA, ROE, ROICACAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • ACAN has a Operating Margin of 16.00%. This is amonst the worse of the industry: ACAN underperforms 83.33% of its industry peers.
  • In the last couple of years the Operating Margin of ACAN has grown nicely.
  • ACAN's Gross Margin of 73.58% is in line compared to the rest of the industry. ACAN outperforms 54.76% of its industry peers.
  • In the last couple of years the Gross Margin of ACAN has remained more or less at the same level.
Industry RankSector Rank
OM 16%
PM (TTM) N/A
GM 73.58%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
ACAN.PA Yearly Profit, Operating, Gross MarginsACAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

More info and screens

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACAN is destroying value.
  • ACAN has more shares outstanding than it did 1 year ago.
  • ACAN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ACAN has a worse debt to assets ratio.
ACAN.PA Yearly Shares OutstandingACAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACAN.PA Yearly Total Debt VS Total AssetsACAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • ACAN has an Altman-Z score of 2.23. This is not the best score and indicates that ACAN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ACAN (2.23) is better than 100.00% of its industry peers.
  • ACAN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • ACAN has a better Debt to Equity ratio (0.01) than 97.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.23
ROIC/WACC0.04
WACC8.07%
ACAN.PA Yearly LT Debt VS Equity VS FCFACAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • ACAN has a Current Ratio of 2.06. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.06, ACAN belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
  • ACAN has a Quick Ratio of 2.06. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.06, ACAN belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 2.06
ACAN.PA Yearly Current Assets VS Current LiabilitesACAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

0

3. Growth

3.1 Past

  • ACAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.34%, which is quite impressive.
  • The Revenue has decreased by -5.50% in the past year.
  • Measured over the past years, ACAN shows a decrease in Revenue. The Revenue has been decreasing by -6.49% on average per year.
EPS 1Y (TTM)85.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.87%
Revenue 1Y (TTM)-5.5%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-9.58%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAN.PA Yearly Revenue VS EstimatesACAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • ACAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACAN.PA Price Earnings VS Forward Price EarningsACAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACAN.PA Per share dataACAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 14.45%, ACAN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 5.30, ACAN pays a better dividend. On top of this ACAN pays more dividend than 97.62% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ACAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 14.45%

5.2 History

  • The dividend of ACAN decreases each year by -46.74%.
Dividend Growth(5Y)-46.74%
Div Incr Years1
Div Non Decr Years1
ACAN.PA Yearly Dividends per shareACAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2023 2024 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

  • The earnings of ACAN are negative and hence is the payout ratio. ACAN will probably not be able to sustain this dividend level.
DP-134.16%
EPS Next 2YN/A
EPS Next 3YN/A
ACAN.PA Yearly Income VS Free CF VS DividendACAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

More info and screens

ACANTHE DEVELOPPEMENT SA

EPA:ACAN (2/4/2026, 7:00:00 PM)

0.245

+0.01 (+2.94%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)09-26
Earnings (Next)04-23
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners55.99%
Ins Owner ChangeN/A
Market Cap40.51M
Revenue(TTM)3.73M
Net Income(TTM)-2.10M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 14.45%
Yearly Dividend0.02
Dividend Growth(5Y)-46.74%
DP-134.16%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.85
P/FCF N/A
P/OCF N/A
P/B 0.36
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.02
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.57%
ROE -1.87%
ROCE 0.48%
ROIC 0.35%
ROICexc 0.35%
ROICexgc 0.35%
OM 16%
PM (TTM) N/A
GM 73.58%
FCFM N/A
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y110.88%
ROICexc growth 3YN/A
ROICexc growth 5Y110.88%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 2.06
Altman-Z 2.23
F-Score4
WACC8.07%
ROIC/WACC0.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.26%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.5%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-9.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y107.12%
EBIT growth 3YN/A
EBIT growth 5Y93.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-178.66%
FCF growth 3YN/A
FCF growth 5Y20.72%
OCF growth 1Y-177.12%
OCF growth 3YN/A
OCF growth 5Y-16.48%

ACANTHE DEVELOPPEMENT SA / ACAN.PA FAQ

What is the ChartMill fundamental rating of ACANTHE DEVELOPPEMENT SA (ACAN.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ACAN.PA.


What is the valuation status of ACANTHE DEVELOPPEMENT SA (ACAN.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to ACANTHE DEVELOPPEMENT SA (ACAN.PA). This can be considered as Overvalued.


How profitable is ACANTHE DEVELOPPEMENT SA (ACAN.PA) stock?

ACANTHE DEVELOPPEMENT SA (ACAN.PA) has a profitability rating of 2 / 10.